Ultralife (NASDAQ:ULBI) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.27 by 55.56 percent. This is a 1100 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $48.481 million which missed the analyst consensus estimate of $57.000 million by 14.95 percent. This is a 10.56 percent increase over sales of $43.852 million the same period last year.